| Stage | IMAX | % of rev | UTI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $103M | 100.00% | $219M | 100.00% | UTI ×2.13 |
| Gross profit | $63M | 61.16% | $219M | 100.00% | UTI +38.8pp |
| Operating income | $21M | 20.20% | $3M | 1.48% | IMAX +18.7pp |
| Pre-tax income | $19M | 18.88% | $3M | 1.42% | IMAX +17.5pp |
| Net income | $16M | 15.47% | $2M | 1.04% | IMAX +14.4pp |
| Stage | IMAX | UTI | Gap · A − B |
|---|---|---|---|
| Revenue | $103M100.00% | $219M100.00% | UTI ×2.13 |
| Gross profit | 61.16%$63M | 100.00%$219M | UTI +38.8pp |
| Operating income | 20.20%$21M | 1.48%$3M | IMAX +18.7pp |
| Pre-tax income | 18.88%$19M | 1.42%$3M | IMAX +17.5pp |
| Net income |
| 15.47%$16M |
| 1.04%$2M |
| IMAX +14.4pp |
No shared counterparties.